{"id":"https://openalex.org/W2090137489","doi":"https://doi.org/10.1097/jom.0b013e31815cff4b","title":"Employees With Fibromyalgia: Medical Comorbidity, Healthcare Costs, and Work Loss","display_name":"Employees With Fibromyalgia: Medical Comorbidity, Healthcare Costs, and Work Loss","publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W2090137489","doi":"https://doi.org/10.1097/jom.0b013e31815cff4b","mag":"2090137489","pmid":"https://pubmed.ncbi.nlm.nih.gov/18188077"},"language":"en","primary_location":{"id":"doi:10.1097/jom.0b013e31815cff4b","doi":"https://doi.org/10.1097/jom.0b013e31815cff4b","is_oa":false,"landing_page_url":"https://doi.org/10.1097/jom.0b013e31815cff4b","pdf_url":null,"source":{"id":"https://openalex.org/S156862075","display_name":"Journal of Occupational and Environmental Medicine","issn_l":"1076-2752","issn":["1076-2752","1536-5948"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Occupational &amp; Environmental Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062117024","display_name":"Leigh Ann White","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79463011","display_name":"Analysis Group (United States)","ror":"https://ror.org/044jp1563","country_code":"US","type":"company","lineage":["https://openalex.org/I79463011"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Leigh Ann White","raw_affiliation_strings":["Analysis Group, Inc., 111 Huntington Avenue, Boston, MA 02199, USA. lwhite@analysisgroup.com","Robinson)","Tang)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analysis Group, Inc., 111 Huntington Avenue, Boston, MA 02199, USA. lwhite@analysisgroup.com","institution_ids":["https://openalex.org/I79463011"]},{"raw_affiliation_string":"Robinson)","institution_ids":[]},{"raw_affiliation_string":"Tang)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111579901","display_name":"Howard G. Birnbaum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I79463011","display_name":"Analysis Group (United States)","ror":"https://ror.org/044jp1563","country_code":"US","type":"company","lineage":["https://openalex.org/I79463011"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howard G. Birnbaum","raw_affiliation_strings":["From Analysis Group, Inc., Boston, Mass (Drs White, Birnbaum, Ms Kaltenboeck, and Mr Tang)","and Eli Lilly and Company, Indianapolis, Ind (Ms Robinson)","Robinson)","Tang)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Analysis Group, Inc., Boston, Mass (Drs White, Birnbaum, Ms Kaltenboeck, and Mr Tang)","institution_ids":["https://openalex.org/I79463011"]},{"raw_affiliation_string":"and Eli Lilly and Company, Indianapolis, Ind (Ms Robinson)","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Robinson)","institution_ids":[]},{"raw_affiliation_string":"Tang)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080311576","display_name":"Anna Kaltenboeck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I79463011","display_name":"Analysis Group (United States)","ror":"https://ror.org/044jp1563","country_code":"US","type":"company","lineage":["https://openalex.org/I79463011"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna Kaltenboeck","raw_affiliation_strings":["From Analysis Group, Inc., Boston, Mass (Drs White, Birnbaum, Ms Kaltenboeck, and Mr Tang)","and Eli Lilly and Company, Indianapolis, Ind (Ms Robinson)","Robinson)","Tang)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Analysis Group, Inc., Boston, Mass (Drs White, Birnbaum, Ms Kaltenboeck, and Mr Tang)","institution_ids":["https://openalex.org/I79463011"]},{"raw_affiliation_string":"and Eli Lilly and Company, Indianapolis, Ind (Ms Robinson)","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Robinson)","institution_ids":[]},{"raw_affiliation_string":"Tang)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066221397","display_name":"Jackson Tang","orcid":"https://orcid.org/0000-0002-1248-9603","observed_orcids":["https://orcid.org/0000-0002-1248-9603"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I79463011","display_name":"Analysis Group (United States)","ror":"https://ror.org/044jp1563","country_code":"US","type":"company","lineage":["https://openalex.org/I79463011"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jackson Tang","raw_affiliation_strings":["From Analysis Group, Inc., Boston, Mass (Drs White, Birnbaum, Ms Kaltenboeck, and Mr Tang)","and Eli Lilly and Company, Indianapolis, Ind (Ms Robinson)","Robinson)","Tang)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Analysis Group, Inc., Boston, Mass (Drs White, Birnbaum, Ms Kaltenboeck, and Mr Tang)","institution_ids":["https://openalex.org/I79463011"]},{"raw_affiliation_string":"and Eli Lilly and Company, Indianapolis, Ind (Ms Robinson)","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Robinson)","institution_ids":[]},{"raw_affiliation_string":"Tang)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111860679","display_name":"David A. Mallett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I79463011","display_name":"Analysis Group (United States)","ror":"https://ror.org/044jp1563","country_code":"US","type":"company","lineage":["https://openalex.org/I79463011"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Mallett","raw_affiliation_strings":["From Analysis Group, Inc., Boston, Mass (Drs White, Birnbaum, Ms Kaltenboeck, and Mr Tang)","and Eli Lilly and Company, Indianapolis, Ind (Ms Robinson)","Robinson)","Tang)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Analysis Group, Inc., Boston, Mass (Drs White, Birnbaum, Ms Kaltenboeck, and Mr Tang)","institution_ids":["https://openalex.org/I79463011"]},{"raw_affiliation_string":"and Eli Lilly and Company, Indianapolis, Ind (Ms Robinson)","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Robinson)","institution_ids":[]},{"raw_affiliation_string":"Tang)","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071285179","display_name":"Rebecca L. Robinson","orcid":"https://orcid.org/0000-0003-1490-0491","observed_orcids":["https://orcid.org/0000-0003-1490-0491"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I79463011","display_name":"Analysis Group (United States)","ror":"https://ror.org/044jp1563","country_code":"US","type":"company","lineage":["https://openalex.org/I79463011"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca L. Robinson","raw_affiliation_strings":["From Analysis Group, Inc., Boston, Mass (Drs White, Birnbaum, Ms Kaltenboeck, and Mr Tang)","and Eli Lilly and Company, Indianapolis, Ind (Ms Robinson)","Robinson)","Tang)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Analysis Group, Inc., Boston, Mass (Drs White, Birnbaum, Ms Kaltenboeck, and Mr Tang)","institution_ids":["https://openalex.org/I79463011"]},{"raw_affiliation_string":"and Eli Lilly and Company, Indianapolis, Ind (Ms Robinson)","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Robinson)","institution_ids":[]},{"raw_affiliation_string":"Tang)","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5062117024"],"corresponding_institution_ids":["https://openalex.org/I79463011"],"apc_list":null,"apc_paid":null,"fwci":12.2181,"has_fulltext":false,"cited_by_count":168,"citation_normalized_percentile":{"value":0.99124964,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"50","issue":"1","first_page":"13","last_page":"24"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11282","display_name":"Fibromyalgia and Chronic Fatigue Syndrome Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11282","display_name":"Fibromyalgia and Chronic Fatigue Syndrome Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12246","display_name":"Chronic Disease Management Strategies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10084","display_name":"Musculoskeletal pain and rehabilitation","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3612","display_name":"Physical Therapy, Sports Therapy and Rehabilitation"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fibromyalgia","display_name":"fibromyalgia","score":1.0},{"id":"https://openalex.org/keywords/osteoarthritis","display_name":"osteoarthritis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.9470000267028809},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.8199999928474426},{"id":"https://openalex.org/keywords/work-loss","display_name":"work loss","score":0.9610000252723694},{"id":"https://openalex.org/keywords/economic-burden","display_name":"economic burden","score":0.7599999904632568},{"id":"https://openalex.org/keywords/prescription-drug-use","display_name":"prescription drug use","score":0.7139999866485596},{"id":"https://openalex.org/keywords/psychiatric-comorbidity","display_name":"psychiatric comorbidity","score":0.7929999828338623},{"id":"https://openalex.org/keywords/chronic-fatigue","display_name":"chronic fatigue","score":0.9290000200271606},{"id":"https://openalex.org/keywords/pain-conditions","display_name":"pain conditions","score":0.7279999852180481}],"concepts":[{"id":"https://openalex.org/C2777831278","wikidata":"https://www.wikidata.org/wiki/Q540571","display_name":"Fibromyalgia","level":2,"score":0.9547606706619263},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7430742383003235},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.6499284505844116},{"id":"https://openalex.org/C6964187","wikidata":"https://www.wikidata.org/wiki/Q659256","display_name":"Indirect costs","level":2,"score":0.5598266124725342},{"id":"https://openalex.org/C3019354653","wikidata":"https://www.wikidata.org/wiki/Q5690885","display_name":"Medical costs","level":3,"score":0.5502490997314453},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.5377163887023926},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.5323605537414551},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.4586903750896454},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.4574443995952606},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3778531551361084},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.18961980938911438},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C121955636","wikidata":"https://www.wikidata.org/wiki/Q4116214","display_name":"Accounting","level":1,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.0},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000041","descriptor_name":"Absenteeism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D004651","descriptor_name":"Employment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005356","descriptor_name":"Fibromyalgia","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D005356","descriptor_name":"Fibromyalgia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D006296","descriptor_name":"Health Services","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010003","descriptor_name":"Osteoarthritis","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D010003","descriptor_name":"Osteoarthritis","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015897","descriptor_name":"Comorbidity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016022","descriptor_name":"Case-Control Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017049","descriptor_name":"Employer Health Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017281","descriptor_name":"Cost of Illness","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/jom.0b013e31815cff4b","doi":"https://doi.org/10.1097/jom.0b013e31815cff4b","is_oa":false,"landing_page_url":"https://doi.org/10.1097/jom.0b013e31815cff4b","pdf_url":null,"source":{"id":"https://openalex.org/S156862075","display_name":"Journal of Occupational and Environmental Medicine","issn_l":"1076-2752","issn":["1076-2752","1536-5948"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Occupational &amp; Environmental Medicine","raw_type":"journal-article"},{"id":"pmid:18188077","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18188077","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of occupational and environmental medicine","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.530.9945","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.530.9945","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.analysisgroup.com/uploadedfiles/publishing/articles/joem_employees_with_fibromyalgia.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"},{"display_name":"Decent work and economic growth","score":0.48510000109672546,"id":"https://metadata.un.org/sdg/8"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1498726486","https://openalex.org/W1521322897","https://openalex.org/W1788454237","https://openalex.org/W1807951500","https://openalex.org/W1923117724","https://openalex.org/W1976913296","https://openalex.org/W1980957263","https://openalex.org/W2008303613","https://openalex.org/W2023064701","https://openalex.org/W2041481324","https://openalex.org/W2060426611","https://openalex.org/W2065256586","https://openalex.org/W2069238845","https://openalex.org/W2069923031","https://openalex.org/W2090417999","https://openalex.org/W2114202011","https://openalex.org/W2129168200","https://openalex.org/W2143964550","https://openalex.org/W2144679750","https://openalex.org/W2157229623","https://openalex.org/W2164094541","https://openalex.org/W2241048149","https://openalex.org/W2316328901","https://openalex.org/W2327489819","https://openalex.org/W2329374376","https://openalex.org/W2341970774","https://openalex.org/W2610860323"],"related_works":["https://openalex.org/W2157611544","https://openalex.org/W2007262715","https://openalex.org/W2341970774","https://openalex.org/W1966139644","https://openalex.org/W2116832351","https://openalex.org/W2342294572","https://openalex.org/W186776021","https://openalex.org/W2175661674","https://openalex.org/W1788454237","https://openalex.org/W2262665300"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"compare":[2],"2005":[3,45],"health":[4],"care":[5],"resources":[6],"among":[7],"matched":[8],"samples":[9,31,83],"of":[10,24,127],"employees":[11,57],"with":[12,36,58,110],"fibromyalgia":[13],"(FM),":[14],"osteoarthritis":[15],"(OA),":[16],"and":[17,29,68,122],"controls.":[18],"METHODS:":[19],"Using":[20],"a":[21],"claims":[22,41,114],"database":[23],"privately":[25],"insured":[26],"individuals,":[27],"FM":[28,59,86,95,101,111,138],"OA":[30,62,89,98,104,116],"were":[32,69],"derived":[33],"from":[34],"those":[35],"two":[37],"or":[38,47],"more":[39,113],"disease-specific":[40,82],"in":[42,49,134],"1999":[43],"to":[44,51,147],"(>":[46],"=1":[48],"2002":[50],"2005).":[52],"RESULTS:":[53],"Total":[54],"costs":[55,63],"for":[56,117],"($10,199)":[60],"approached":[61],"($10,861,":[64],"P":[65,75,91,106],"=":[66],"0.3758)":[67],"significantly":[70],"higher":[71],"than":[72,115],"controls":[73],"($5274,":[74],"<":[76,92,107],"0.0001).":[77,108],"Cost":[78],"components":[79],"varied":[80],"across":[81],"(direct":[84],"medical:":[85],"$7286":[87],"vs":[88,97,103],"$8325,":[90],"0.0287;":[93],"pharmacy:":[94],"$1630":[96],"$1341;":[99],"indirect:":[100],"$2913":[102],"$2537,":[105],"Employees":[109],"had":[112],"psychiatric":[118],"diagnoses,":[119],"chronic":[120],"fatigue,":[121],"most":[123],"pain":[124],"conditions.":[125],"Use":[126],"multiple":[128],"prescription":[129],"drug":[130],"classes":[131],"was":[132],"common":[133],"both":[135],"samples.":[136],"CONCLUSIONS:":[137],"imposes":[139],"significant":[140],"economic":[141],"burden.":[142],"Work":[143],"loss":[144],"contributes":[145],"substantially":[146],"the":[148],"impact.":[149]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":15}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}